Future studies are necessary to address the translational potential of targeting OPN following stroke with regard to whether the absence of OPN and the formation of additional cholesterol crystals actually leads to a worse overall outcome at time points later than seven weeks. The gene discussed is SPP1; the disease is Stroke.